FGEN
FibroGen Inc
Price:  
0.35 
USD
Volume:  
503,571.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN WACC - Weighted Average Cost of Capital

The WACC of FibroGen Inc (FGEN) is 7.3%.

The Cost of Equity of FibroGen Inc (FGEN) is 11.85%.
The Cost of Debt of FibroGen Inc (FGEN) is 5.50%.

Range Selected
Cost of equity 10.10% - 13.60% 11.85%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.7% - 8.8% 7.3%
WACC

FGEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.35 1.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.10% 13.60%
Tax rate 0.10% 0.20%
Debt/Equity ratio 2.61 2.61
Cost of debt 4.00% 7.00%
After-tax WACC 5.7% 8.8%
Selected WACC 7.3%